Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Michael Mancino

Concepts (132)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Opioid-Related Disorders
14
2025
393
3.180
Why?
Buprenorphine
8
2023
145
2.630
Why?
Amphetamine-Related Disorders
5
2024
93
2.180
Why?
Methamphetamine
5
2024
194
2.020
Why?
Cocaine-Related Disorders
7
2025
209
1.860
Why?
Methadone
7
2025
183
1.740
Why?
Opiate Substitution Treatment
9
2025
99
1.590
Why?
Central Nervous System Stimulants
2
2024
209
1.410
Why?
Substance Withdrawal Syndrome
5
2021
168
1.180
Why?
Disulfiram
3
2025
13
1.170
Why?
Alcohol Deterrents
2
2025
11
1.070
Why?
Tai Ji
1
2023
22
0.840
Why?
Patient Discharge
1
2024
321
0.770
Why?
Dextroamphetamine
1
2021
39
0.760
Why?
Analgesics, Opioid
6
2023
575
0.720
Why?
Sertraline
3
2017
46
0.680
Why?
Patient Compliance
3
2016
233
0.660
Why?
Narcotics
3
2025
112
0.640
Why?
Cyclohexanecarboxylic Acids
2
2014
20
0.560
Why?
Amines
2
2014
41
0.550
Why?
Double-Blind Method
6
2025
708
0.550
Why?
gamma-Aminobutyric Acid
2
2014
65
0.540
Why?
Adult
21
2025
13577
0.530
Why?
Child Abuse
1
2016
136
0.470
Why?
Depression
3
2014
582
0.460
Why?
Stress Disorders, Post-Traumatic
2
2010
383
0.430
Why?
Methadyl Acetate
2
2010
11
0.420
Why?
Young Adult
7
2024
4102
0.420
Why?
Male
21
2025
25907
0.410
Why?
Female
22
2025
27081
0.400
Why?
Humans
27
2025
50503
0.380
Why?
Reward
1
2010
115
0.340
Why?
Middle Aged
13
2025
12611
0.330
Why?
Dose-Response Relationship, Drug
6
2025
1372
0.330
Why?
Behavior Therapy
1
2010
185
0.300
Why?
Diagnosis, Dual (Psychiatry)
3
2014
41
0.290
Why?
Treatment Outcome
6
2025
5283
0.280
Why?
Pilot Projects
4
2021
698
0.280
Why?
Cocaine
3
2025
182
0.270
Why?
Quality-Adjusted Life Years
1
2006
63
0.270
Why?
Narcotic Antagonists
4
2021
136
0.240
Why?
Anxiety
2
2022
285
0.240
Why?
Retrospective Studies
6
2022
6263
0.240
Why?
Health Status
1
2006
299
0.230
Why?
Veterans
2
2010
574
0.230
Why?
Combined Modality Therapy
4
2017
641
0.230
Why?
Substance-Related Disorders
2
2024
611
0.220
Why?
Patient Admission
1
2024
76
0.220
Why?
Databases, Factual
2
2019
673
0.200
Why?
Adolescent
4
2024
6443
0.190
Why?
Time Factors
4
2011
2935
0.180
Why?
Outpatients
1
2022
117
0.180
Why?
Quality of Life
1
2006
851
0.180
Why?
Naloxone
2
2013
81
0.180
Why?
Pain
1
2023
387
0.170
Why?
Chromatography, High Pressure Liquid
1
2021
326
0.170
Why?
Tandem Mass Spectrometry
1
2021
238
0.170
Why?
Health Services Accessibility
1
2024
424
0.170
Why?
Self Report
3
2016
206
0.160
Why?
Patient Dropouts
2
2016
52
0.160
Why?
Prescription Drug Misuse
1
2019
34
0.160
Why?
Drug Monitoring
1
2019
79
0.160
Why?
Substance Abuse Treatment Centers
2
2024
79
0.140
Why?
Ambulatory Care
2
2016
230
0.140
Why?
Cross-Sectional Studies
2
2016
1610
0.140
Why?
Age Factors
2
2010
1110
0.140
Why?
Life Change Events
1
2016
36
0.130
Why?
Prevalence
2
2016
971
0.130
Why?
Prospective Studies
3
2021
2378
0.110
Why?
GABA Agonists
1
2014
14
0.110
Why?
Logistic Models
1
2016
900
0.110
Why?
Risk-Taking
1
2014
107
0.110
Why?
Diltiazem
1
2013
10
0.110
Why?
Excitatory Amino Acid Antagonists
1
2013
51
0.110
Why?
Verapamil
1
2013
22
0.110
Why?
Suicidal Ideation
1
2014
97
0.100
Why?
Drug Therapy, Combination
1
2014
384
0.100
Why?
Suicide
1
2014
83
0.100
Why?
Calcium Channel Blockers
1
2013
62
0.100
Why?
Medication Adherence
1
2014
129
0.100
Why?
Recurrence
1
2014
659
0.100
Why?
Motivation
1
2014
275
0.100
Why?
Internet
1
2014
259
0.100
Why?
Electrocardiography
1
2013
266
0.090
Why?
Severity of Illness Index
3
2013
978
0.090
Why?
Token Economy
1
2010
33
0.090
Why?
Substance Abuse Detection
1
2010
90
0.090
Why?
Affect
1
2011
103
0.090
Why?
Income
1
2010
104
0.090
Why?
Hospitals, Veterans
1
2010
111
0.080
Why?
Psychiatric Status Rating Scales
2
2011
318
0.080
Why?
Choice Behavior
1
2010
83
0.080
Why?
Sleep
1
2011
181
0.080
Why?
Heart Rate
1
2011
307
0.080
Why?
Benzhydryl Compounds
1
2009
64
0.080
Why?
Survival Analysis
1
2010
661
0.080
Why?
Blood Pressure
1
2011
531
0.070
Why?
Cognition
1
2011
346
0.070
Why?
Arkansas
1
2014
1985
0.070
Why?
Socioeconomic Factors
1
2010
591
0.070
Why?
Personality Inventory
1
2006
48
0.070
Why?
Child
2
2016
6906
0.070
Why?
United States
2
2024
4955
0.070
Why?
Combat Disorders
1
2006
37
0.070
Why?
Psychometrics
1
2006
232
0.060
Why?
Comorbidity
1
2006
623
0.060
Why?
Depressive Disorder
1
2006
335
0.060
Why?
Single-Blind Method
1
2023
114
0.050
Why?
Secondary Prevention
2
2013
79
0.050
Why?
Limit of Detection
1
2021
16
0.050
Why?
Linear Models
1
2021
279
0.040
Why?
Postpartum Period
1
2021
102
0.040
Why?
Randomized Controlled Trials as Topic
1
2023
573
0.040
Why?
Effect Modifier, Epidemiologic
1
2017
7
0.040
Why?
Reproducibility of Results
1
2021
1197
0.040
Why?
Predictive Value of Tests
1
2019
930
0.030
Why?
Chronic Pain
1
2019
182
0.030
Why?
Emergency Service, Hospital
1
2019
484
0.030
Why?
Risk Assessment
1
2019
1270
0.030
Why?
Pregnancy
1
2021
2452
0.030
Why?
Directly Observed Therapy
1
2013
7
0.030
Why?
Maintenance Chemotherapy
1
2013
48
0.030
Why?
Residence Characteristics
1
2014
150
0.030
Why?
Diagnostic and Statistical Manual of Mental Disorders
1
2013
74
0.030
Why?
Induction Chemotherapy
1
2013
59
0.030
Why?
Calcium Channels, L-Type
1
2013
68
0.030
Why?
Drug Interactions
1
2013
206
0.030
Why?
Placebos
1
2011
87
0.020
Why?
Kaplan-Meier Estimate
1
2011
464
0.020
Why?
Alcohol Drinking
1
2010
227
0.020
Why?
Sex Characteristics
1
2008
198
0.020
Why?
Aged
1
2014
9741
0.010
Why?
Mancino's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description